Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W V Miller

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Transfusion|July 1, 1973
Simple methods for productions of HL-A antigen poor red blood cellsW V Miller, M J Wilson, H J Kalb
Transfusion|November 1, 1982
Impact of the anticoagulant-preservative citrate-phosphate-adenine (CPDA-1) on blood servicesP M McEvoy, R A Kahn, W V Miller
Transfusion|October 1, 1991
Antibodies to hepatitis C virus and surrogate marker testing of blood donors to prevent non-A, non-B hepatitisR Kakaiya, J Stephans, G Carnahan, et al.
Vox Sanguinis|January 1, 1978
Effect of centrifugation and subsequent storage on red blood cellsD J Ladd, V Silva, J J Riggio, et al.
Lancet (London, England)|April 19, 1975
Effect on cytotoxicity antibodies in potential transplant recipients of leucocyte-poor blood-transfusionW V Miller, R Schmidt, R G Luke, et al.
JAMA|November 9, 1979
Use of plasma products with whole blood and packed RBCsR A Kahn, S D Staggs, W V Miller, et al.
Vox Sanguinis|July 1, 1971
Evaluation of the effectiveness of hepatitis screening testsW V Miller, L E Watson, P V Holland, et al.
Veterinary Medicine, Small Animal Clinician : VM, SAC|August 1, 1981
Efficacy of an oral larvicide in controlling horse botsA J Sharp, R G Pennington, M G Scroggs, et al.
Critical Care Update|May 1, 1980
Transfusion therapyN Gianino, R Rutman, D Casey, et al.
Vox Sanguinis|January 1, 1985
How should we handle the ethical questions regarding information to donors and patients and the practical implications regarding deferral of donors and handling of donated blood in the event of introducing a screening test for HTLV-III as in order to prevent transmission of AIDS by blood transfusion?J R Bove, R Y Dodd, W V Miller, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Transfusion|July 1, 1973
Simple methods for productions of HL-A antigen poor red blood cellsW V Miller, M J Wilson, H J Kalb
Transfusion|November 1, 1982
Impact of the anticoagulant-preservative citrate-phosphate-adenine (CPDA-1) on blood servicesP M McEvoy, R A Kahn, W V Miller
Transfusion|October 1, 1991
Antibodies to hepatitis C virus and surrogate marker testing of blood donors to prevent non-A, non-B hepatitisR Kakaiya, J Stephans, G Carnahan, et al.
Vox Sanguinis|January 1, 1978
Effect of centrifugation and subsequent storage on red blood cellsD J Ladd, V Silva, J J Riggio, et al.
Lancet (London, England)|April 19, 1975
Effect on cytotoxicity antibodies in potential transplant recipients of leucocyte-poor blood-transfusionW V Miller, R Schmidt, R G Luke, et al.
JAMA|November 9, 1979
Use of plasma products with whole blood and packed RBCsR A Kahn, S D Staggs, W V Miller, et al.
Vox Sanguinis|July 1, 1971
Evaluation of the effectiveness of hepatitis screening testsW V Miller, L E Watson, P V Holland, et al.
Veterinary Medicine, Small Animal Clinician : VM, SAC|August 1, 1981
Efficacy of an oral larvicide in controlling horse botsA J Sharp, R G Pennington, M G Scroggs, et al.
Critical Care Update|May 1, 1980
Transfusion therapyN Gianino, R Rutman, D Casey, et al.
Vox Sanguinis|January 1, 1985
How should we handle the ethical questions regarding information to donors and patients and the practical implications regarding deferral of donors and handling of donated blood in the event of introducing a screening test for HTLV-III as in order to prevent transmission of AIDS by blood transfusion?J R Bove, R Y Dodd, W V Miller, et al.
Pageof 6